DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA. Joshi R, Qin L, Cao X, Zhong S, et al. J Biol Chem 2020;295:645-656.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Joshi R, Qin L, Cao X, Zhong S, et al. DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA. J Biol Chem 2020;295:645-656.
PMID: 31806702